ArticleJournal for immunotherapy of cancerPublished
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Journal for immunotherapy of cancer
- Published
- Topic
- Disease research
- Subject terms
- Animals; Mice, Transgenic; Humans; Mice; Melanoma; Disease Models, Animal; Peptides; Antineoplastic Agents; Antibodies, Monoclonal; Tumor Microenvironment; CTLA-4 Antigen; Ipilimumab
- PubMed ID
- 38164757
- PubMed Central ID
- PMC10729150
- Open access
- Yes, open
- Added to directory
- Source checked